Ukungcola kwe-amino acid esetshenziselwa ukuhlanganisa amaprotheni
Imininingwane Yomkhiqizo
| NO | Imikhiqizo | Cas cha | Isikhombi sekhwalithi esemqoka | |||
| Ubumsulwa | UMax. ukungcola | Inani eliphelele le-solvent | Ubumanzi | |||
| 1 | FMoc-β-Ala-Ala-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 2 | I-FMOC-D-ALA-D-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 3 | I-FMOC-β-Ala-D-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 4 | I-FMOC-ALF (PBF) -Arg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 5 | I-FMOC-β-Ala-arg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 6 | I-FMOC-D-ALF (PBF) -D-Off (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 7 | I-FMoc-β-Ala-D-arg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 8 | I-FMoc-Homoarg (PBF) -Homoarg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 9 | I-FMoc-β-Ala-Homoarg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 10 | I-FMOC-ASN (TRT) -ASN (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 | I-FMOC-β-Ala-ASN (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 12 | I-FMOC-ASP (OTBU) -APP (OTBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 13 | I-FMOC-β-Ala-ASP (OTBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 14 | I-FMOC-CYS (TRT) -Cys (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 15 | FMoc-β-Ala-Cys (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 16 | I-FMOC-CYS (ACM) -Cys (ACM) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 17 | FMoc-β-Ala-Cys (ACM) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 18 | I-FMOC-GLN (TRT) -GGN (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 19 | FMoc-β-Ala-GLN (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 20 | I-FMOC-Glu (OTBU) -Glu (OtBu) -Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 21 | FMoc-β-Ala-Glu (Otbu) -Oh.h2o | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 22 | I-FMoc-β-Ala-Gly-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 23 | I-FMoc-yakhe (TRT) -His (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 24 | I-FMOC-β-Ala-yakhe (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 25 | I-FMOC-ile-ile-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 26 | I-FMoc-β-Ala-ile-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 27 | FMoc-leu-leu-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 28 | I-FMoc-β-Ala-Leu-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 29 | I-FMOC-D-leu-d-leu-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 30 | I-FMoc-β-Ala-D-leu-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 31 | I-FMOC-LYS (BOC) -Light (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 32 | I-FMoc-β-Ala-Lys (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 33 | I-FMOC-LYS (AllOC) -Lity (AllOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 34 | FMoc-β-Ala-Lys (AllOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 35 | I-FMOC-Met-Met-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 36 | I-FMoc-β-Ala-Met-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 37 | I-FMOC-ORN (BOC) - (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 38 | I-FMoc-β-Ala-Orn (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 39 | I-FMOC-Phe-Phe-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 40 | I-FMoc-β-Ala-phe-phehe-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 41 | I-FMOC-D-PHE-D-phe-phehe-phhe | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 42 | FMoc-β-Ala-D-phe-phehe-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 43 | I-FMOC-pro-pro-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 44 | I-FMOC-β-Ala-Pro-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 45 | I-FMOC-ser (TBU) -Ser (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 46 | FMoc-β-Ala-Ser (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 47 | I-FMOC-SER (TRT) -SER (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 48 | I-FMoc-β-Ala-Ser (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 49 | I-FMOC-Thrist (TBU) -Li) -Th (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 50 | I-FMOC-β-Ala-Thr (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 51 | I-FMOC-TRP (BOC) -TRP (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 52 | FMoc-β-Ala-TRP (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 53 | I-FMOC-D-TRP (BOC) -D-TRP (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 54 | I-FMoc-β-Ala-D-TRP (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 55 | I-FMoc-Tyr (TBU) -TYR (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 56 | FMoc-β-Ala-Tyr (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 57 | I-FMOC-D-TRY (ET) -D-TRY (ET) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 58 | I-FMoc-β-Ala-D-TRY (ET) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 59 | I-FMoc-Tyr (Me) -YRRR (Me) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 60 | FMoc-β-Ala-Tyr (Me) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 61 | FMoc-Val-Val-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 62 | I-FMoc-β-Ala-Val-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 63 | I-FMOC-D-cit-D-AIT-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 64 | FMoc-β-Ala-D-AIT-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 65 | I-FMoc-β-Ala-Dab-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 66 | I-FMOC- (3- (2-Naphthyl) -D-ALA) 2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 67 | I-FMOC-β-Ala-3- (2-Naphthyl) -D-Ala-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 68 | I-FMOC- (3- (3-Pyridinyl) -D-ALA) 2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 69 | FMoc-β-Ala-3- (3-Pyridinyl) -D-Ala-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 70 | I-FMOC- (4-Chloro-D-PH) 2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 71 | I-FMoc-β-Ala-4-Chloro-D-phe-phehe-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 72 | I-FMOC- (D-4AF (TBUCBM)) 2-O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 73 | I-FMOC-β-Ala-D-44) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 74 | I-FMOC-APH (L-HOR) -AP (L-HOR) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 75 | I-FMOC-β-Ala-APH (L-HOR) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 76 | I-FMOC-LYS (IPR, BOC) -Light (IPR, BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 77 | I-FMoc-β-Ala-Lys (IPR, BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 78 | I-FMoc-β-Ala-Aeea-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 79 | I-FMOC-AIB-AIB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 80 | I-FMoc-β-Ala-Aib-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 81 | I-FMOC-arg-Oh | 91000-69-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 82 | I-H-arg (PBF) -OH | 200115-86-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 83 | I-FMOC-D-Off-Oh | 130752-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 84 | I-HD-ALF (PBF) -OH | 200116-81-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 85 | FMoc-Homoarg-Ohcl | 208174-14-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 86 | H-homoarg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 87 | I-FMOC-D-Homoarg-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 88 | HD-HoMOARG (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 89 | I-FMOC-ASN-OH | 71989-16-7-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 90 | I-H-ASN (TRT) -OH | 132388-58-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 91 | I-FMOC-ASP-OH | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 92 | I-H-ASP (OTBU) -OH | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 93 | I-FMOC-CYS-OH | 135248-89-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 94 | H-CYS (TRT) -OH | 2799/7/7/7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 95 | H-CYS (ACM) -OH.hcl | 28798-28-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 96 | I-FMOC-GLN-OH | 71989-20-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 97 | I-H-GLN (TRT) -OH | 102747-84-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 98 | I-FMOC-Glu-OH | 121343-82-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 99 | I-H-Glu (OTBU) -OH.h2O | 2419-56-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 100 | I-FMOC-OH | 116611-64-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 101 | H-her (trit) -Oh | 35146-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 102 | Boc-yakhe-oh | 17791-52-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 103 | I-FMOC-LYS-OH | 105047-45-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-104 | I-H-LYS (BOC) -OH | 2418-95-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 105 | I-H-LYS (AllOC) -OH | 6298/3/9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-106 | I-FMOC-ORN-OH.HCL | 201046-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-107 | I-H-ORN (BOC) -OH | 13650-49-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-108 | I-FMOC-ser-oh | 73724-45-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 109 | I-H-Ser (TBU) -OH | 18822-58-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 | I-H-Ser (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 111 | I-FMOC-Thr-Oh.h2o | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 112 | H-Three (TBU) -OH | 4378-13-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 113 | I-FMOC-TRP-OH | 35737-15-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 114 | I-H-TRP (BOC) -OH | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 115 | I-FMOC-D-TRP-OH | 86123-11-7-7-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-116 | I-HD-TRP (BOC) -OH | 201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-117 | I-FMoc-Tyr-Oh | 92954-90-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 118 | I-H-TR (TBU) -OH | 18822-59-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 119 | I-FMOC-D-TRY-OH | 112883-29-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-120 | I-HD-Tyr (ET) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 121 | H-tyr (me) -h.hcl | 67423-44-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 122 | I-FMOC-D-4APH (CBM) -OH | 324017-22-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 123 | I-HD-4AP (TBUCBM) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 124 | I-FMOC-LYS (IPR) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 125 | I-H-LYS (IPR, BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
Maqondana
Imbuyiselo
I-GentoLex inikezela ngemikhiqizo esezingeni eliphakeme, uma noma iyiphi ikhwalithi yomkhiqizo ephakanyiswa yiklayenti ngaphakathi kwesikhathi esidingekayo esinobufakazi obanele, sizohlinzeka ngokuhlaziywa okudingekayo nokuhlola ukuze kubangele izinqubo zezinxephezelo.
Umkhiqizo
Amakhono wemikhiqizo yezemithi afinyelela ebangeni lamathani, amakhono wemikhiqizo yamakhemikhali afinyelela kuma-100tons + ebangeni, amakhono ahlomele kahle ukusebenzela amaklayenti emhlabeni jikelele.
Ucwaningo Nentuthuko
Njalo ngonyaka, kunohlelo lokusetha yiqembu le-R & D ukuthuthukisa imikhiqizo emisha ehlukene, lapho amatshe ahlosiwe, wonke amalungu eqenjini kuzodingeka aqhubeke nomsebenzi weKPI kanye nenqubomgomo yokukhuthaza.
